Quick Answer
INOVIO PHARMACEUTICALS, INC. reported Total Revenue of $65.3 thousand for fiscal year 2025.
INOVIO PHARMACEUTICALS, INC. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $65.3K | -70.0% |
| 2024 | $217.8K | -73.8% |
| 2023 | $832.0K | -91.9% |
| 2022 | $10.26M | +478.2% |
| 2021 | $1.77M | -76.1% |
| 2020 | $7.41M | +80.2% |
| 2019 | $4.11M | -86.5% |
| 2018 | $30.48M | -27.8% |
| 2017 | $42.22M | +19.4% |
| 2016 | $35.37M | -12.8% |
| 2015 | $40.57M | +288.0% |
| 2014 | $10.46M | -22.4% |
| 2013 | $13.47M | +227.0% |
| 2012 | $4.12M | -58.0% |
| 2011 | $9.80M | +59.4% |
| 2010 | $6.14M | -32.6% |
| 2009 | $9.12M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.00 | — | — |
| June 30, 2025 | $0.00 | -100.0% | -100.0% |
| March 31, 2025 | $65.3K | — | — |
| September 30, 2024 | $0.00 | -100.0% | -100.0% |
| June 30, 2024 | $100.8K | -55.4% | — |
| March 31, 2024 | $0.00 | -100.0% | -100.0% |
| September 30, 2023 | $388.4K | -95.8% | +71.9% |
| June 30, 2023 | $226.0K | -71.2% | +96.6% |
- INOVIO PHARMACEUTICALS, INC. showed a decrease of -70.0% in Total Revenue compared to the prior fiscal year.
- Over the 2009–2025 period, INOVIO PHARMACEUTICALS, INC.’s total revenue has declined by 99.3% (from $9.12 million to $65.3 thousand).
- The most recent figure is from INOVIO PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: